PALM SPRINGS, Calif., Aug. 24, 2026 /PRNewswire/ — The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are presented during The VEINS and VIVA 2026, taking place October 3-6 at Bellagio Las Vegas. The highly anticipated late-breaking…
Tag: VIVA
Late-Breaking Clinical Trial Results Announced at The VEINS 2025
LAS VEGAS, Nov. 2, 2025 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine through education and research, today announced results from the Late-Breaking Clinical Trials presented at The VEINS 2025 conference, held at…
Vascular Innovation on Display: The VIVA Foundation Set to Unveil Latest Trial Data at The VEINS and VIVA 2025
PALM SPRINGS, Calif., Sept. 10, 2025 /PRNewswire/ — The VIVA Foundation will once again showcase the most influential new data in vascular medicine on a global stage. From Saturday, November 1, through Tuesday, November 4, results from 23 clinical trials will be presented during The…
Final Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24
LAS VEGAS, Nov. 5, 2024 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds of Late-Breaking Clinical Trials presented at…
First Rounds of Late-Breaking Clinical Trial Results Announced at VIVA24
LAS VEGAS, Nov. 4, 2024 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first two rounds of Late-Breaking Clinical Trials presented at…
First-on-Podium Data from 21 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2024
PALM SPRINGS, Calif., Sept. 6, 2024 /PRNewswire/ — Leading physicians and researchers will present results from 21 clinical trials from Sunday, November 3, to Tuesday, November 5, at the annual VIVA and The VEINS conferences at Wynn Las Vegas. VIVA (Vascular InterVentional Advances) is a…
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA23
LAS VEGAS, Nov. 1, 2023 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the last of four Late-Breaking Clinical Trial sessions at the VIVA23…
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23
LAS VEGAS, Nov. 1, 2023 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four Late-Breaking Clinical Trial sessions at the VIVA23…
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA23
LAS VEGAS, Oct. 31, 2023 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four Late-Breaking Clinical Trial sessions at the…
Late-Breaking Clinical Trial Results Announced at The VEINS 2023
LAS VEGAS, Oct. 30, 2023 /PRNewswire/ — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the Late-Breaking Clinical Trials session at The VEINS conference,…


